Login / Signup

Combination treatment with varenicline and naltrexone reduces World Health Organization risk drinking levels.

Steven J NietoCraig K EndersKatie A WitkiewitzStephanie S O'MalleyLara A Ray
Published in: Alcoholism, clinical and experimental research (2022)
These findings provide evidence that combined varenicline plus naltrexone treatment is effective at reducing WHO risk drinking levels, particularly among individuals who smoke cigarettes daily and drink heavily. These results add to a growing body of literature validating reductions in WHO risk drinking levels as outcomes of alcohol medication trials.
Keyphrases
  • smoking cessation
  • alcohol consumption
  • healthcare
  • metabolic syndrome
  • insulin resistance
  • drug induced